When blood glucose falls below its normal range, the body launches a coordinated, multi-step counterattack designed to push sugar back into the bloodstream. The process starts in the pancreas, loops through the liver, recruits the brain and adrenal glands, and reaches all the way to fat tissue. Each step has built-in redundancy: if one mechanism fails, another picks up the slack. Understanding the sequence helps explain not just normal physiology but also why people with diabetes can lose the ability to sense and correct low blood sugar.
The Starting Signal in the Pancreas
The first responders to falling blood glucose are cells sitting right inside the pancreatic islets. Alpha cells, which produce glucagon, act as the body’s primary low-glucose sensors. These cells contain an enzyme called glucokinase that functions as an internal glucose meter. When glucose concentrations drop, glucokinase activity decreases, and that shift triggers the alpha cell to release glucagon into the bloodstream. Research has confirmed that knocking down glucokinase in alpha cells completely abolishes their ability to adjust glucagon output in response to changing glucose levels, proving that this enzyme is the critical link between glucose sensing and hormone release.1Scientific Reports. Glucokinase intrinsically regulates glucose sensing and glucagon secretion in pancreatic alpha cells
At the same time, beta cells in the same islets reduce their insulin output. Beta cells work as glucose sensors too, but in the opposite direction: when glucose is high, they ramp up insulin secretion; when it falls, they scale back. The mechanism depends on changes in the cell’s electrical activity and calcium signaling that slow the release of insulin-containing granules.2PubMed Central. Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men This simultaneous rise in glucagon and drop in insulin is the earliest hormonal shift in the counterregulatory cascade, and it happens within minutes of glucose beginning to fall.
What Glucagon Does in the Liver
Glucagon’s main target is the liver, which stores glucose in a compacted form called glycogen. Between meals, or whenever blood sugar dips, the liver breaks glycogen apart and releases free glucose into the blood. The enzyme that does most of the heavy lifting is glycogen phosphorylase, which snips individual glucose units off the glycogen chain.3PubMed. Role of glycogen phosphorylase in liver glycogen metabolism Those units pass through a couple of chemical conversions before emerging as free glucose that can enter the bloodstream.4Experimental & Molecular Medicine. Regulation of glucose metabolism from a liver-centric perspective
Glucagon activates this breakdown by binding to receptors on liver cells and raising levels of a signaling molecule called cyclic AMP inside those cells. This was one of the earliest breakthroughs in glucagon research, established decades ago, and remains a central feature of how we understand the hormone.5PubMed. Glucagon–Early breakthroughs and recent discoveries The liver stores enough glycogen to sustain blood glucose for roughly a day of fasting. After that, glucagon also stimulates gluconeogenesis, a process in which the liver manufactures new glucose from non-sugar raw materials like amino acids and glycerol.
The Brain Steps In
The pancreas is not the only organ monitoring glucose. The brain, which consumes a disproportionate share of the body’s glucose supply, has its own populations of glucose-sensing neurons. These neurons sit primarily in the hypothalamus and brainstem, and they respond to glucose concentrations falling below roughly 5 millimoles per liter. When they detect a drop, they fire signals through multiple channels: the autonomic nervous system (both its sympathetic and parasympathetic branches), the hormonal axis connecting the hypothalamus to the pituitary and adrenal glands, and even by releasing the hormone vasopressin from the posterior pituitary.6PubMed. Neuronal glucose sensing mechanisms and circuits in the control of insulin and glucagon secretion
This neural input matters because it amplifies and fine-tunes the pancreatic response. Sympathetic nerve fibers running directly to the islets can stimulate alpha cells and suppress beta cells even before circulating glucagon levels have changed much. The brain essentially adds a second layer of control on top of what the pancreas does on its own, ensuring that the counterregulatory response is fast and strong enough to protect itself from running out of fuel.
Adrenaline and the Adrenal Glands
If glucose continues to drop, the sympathetic nervous system triggers the adrenal glands to dump adrenaline (epinephrine) into the bloodstream. Adrenaline is increasingly recognized as a major metabolic hormone, not just a stress chemical: it mobilizes both glucose and fatty acids to provide energy during hypoglycemia or physical exertion.7PubMed Central. Adrenaline: insights into its metabolic roles in hypoglycaemia and diabetes In the liver, adrenaline reinforces glucagon’s effect by further stimulating glycogen breakdown. In muscle, it promotes the release of lactate, which travels to the liver and gets converted into glucose. And in fat tissue, it activates lipolysis, releasing fatty acids that muscles and other organs can burn instead of glucose, effectively sparing glucose for the brain.
One detail that often surprises people is that the glucose threshold for triggering adrenaline release differs between men and women. In one study, the glucose level that prompted a rise in epinephrine, norepinephrine, and cortisol was about 9 mg/dL higher in men, meaning their counterregulatory hormones kicked in at a relatively less severe degree of low blood sugar.8Metabolism. Gender influences counterregulatory hormone responses to hypoglycemia The practical significance of this sex difference is still debated, but it highlights that the glucose threshold for each step of the counterregulatory cascade is not identical across all people.
Slower Hormonal Reinforcements
Glucagon and adrenaline are the fast responders, working within minutes. Behind them come cortisol and growth hormone, which take longer to ramp up but sustain the counterregulatory effort over hours. Cortisol, released from the adrenal cortex through the hypothalamic-pituitary-adrenal axis, reduces glucose uptake by muscle and fat and stimulates gluconeogenesis in the liver. Growth hormone, released from the pituitary, works along similar lines, helping to keep glucose available for the brain during prolonged fasting or extended hypoglycemia.
These slower hormones are not always reliable. In a study of over 100 patients admitted with severe hypoglycemia and type 2 diabetes, roughly one in five had a blunted cortisol response, and nearly three-quarters had a blunted growth hormone response.9PubMed Central. Impaired Cortisol and Growth Hormone Counterregulatory Responses among Severe Hypoglycemic Patients with Type 2 Diabetes Mellitus Older age and higher body mass were associated with these impairments. This is one reason why severe low blood sugar can be particularly dangerous in older adults with diabetes: their backup hormonal systems may not work as expected.
What Happens in Fat and Muscle
The counterregulatory hormones do not just act on the liver. Fat tissue is a major secondary responder. When adrenaline rises during hypoglycemia, it activates receptors on fat cells that trigger the breakdown of stored fat into glycerol and free fatty acids. This process, called lipolysis, is regulated through both alpha- and beta-adrenergic mechanisms.10PubMed. Stimulation of adipose tissue lipolysis following insulin-induced hypoglycaemia: evidence of increased beta-adrenoceptor-mediated lipolytic response in IDDM The free fatty acids serve as an alternative fuel source for muscles and many other tissues, reducing their demand for glucose and leaving more of it available for the brain, which cannot efficiently burn fat.
An interesting finding from the same research was that people with type 1 diabetes showed a lipolytic response that was about twice as large as in people without diabetes, despite having a weaker adrenaline response.10PubMed. Stimulation of adipose tissue lipolysis following insulin-induced hypoglycaemia: evidence of increased beta-adrenoceptor-mediated lipolytic response in IDDM Their fat cells appeared to be more sensitive to the adrenaline that was present. This kind of compensatory upregulation suggests the body adapts at the tissue level to make up for deficiencies in the overall hormonal response.
Symptoms as Built-In Alarms
The hormonal changes described above are not silent. They produce symptoms that serve as an early warning system, alerting you that blood glucose is falling and you need to eat. These symptoms fall into two distinct categories depending on their origin.
The first group, called neurogenic symptoms, comes from the autonomic nervous system activation triggered by the counterregulatory response. They split further into two types based on which branch of the autonomic system drives them:
- Adrenergic symptoms: shakiness, heart pounding, and anxiety, driven by adrenaline and sympathetic nerve activation
- Cholinergic symptoms: sweating, hunger, and tingling, driven by parasympathetic nerve activation
The second group, called neuroglycopenic symptoms, results from the brain itself running short on glucose. These include warmth, weakness, difficulty thinking or confusion, and drowsiness.11PubMed Central. Neuroendocrine Responses to Hypoglycemia Neuroglycopenic symptoms are harder to recognize because they do not feel as dramatic or alarming as a pounding heart or trembling hands. Research has confirmed that people primarily perceive hypoglycemia through the neurogenic symptoms rather than the neuroglycopenic ones.12PubMed. Mechanism of awareness of hypoglycemia. Perception of neurogenic (predominantly cholinergic) rather than neuroglycopenic symptoms
If glucose keeps dropping without correction, neuroglycopenic symptoms progress from mild confusion to severe cognitive failure, seizures, and eventually coma.13PubMed. Symptoms of hypoglycemia, thresholds for their occurrence, and hypoglycemia unawareness This progression tracks the degree of brain glucose deprivation and represents a medical emergency.
When the Alarm System Fails
One of the most clinically significant complications related to this cascade is a condition called hypoglycemia-associated autonomic failure, or HAAF. In people with diabetes who experience repeated episodes of low blood sugar, the body’s counterregulatory thresholds gradually shift downward. Glucagon responses may disappear entirely (a feature linked to the loss of the normal drop in insulin within the islets that usually signals alpha cells to release glucagon). Adrenaline responses become blunted. And with weakened adrenaline responses come weakened neurogenic symptoms, meaning the person loses the ability to feel that their blood sugar is dangerously low.14PubMed. Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in diabetes
This creates a vicious cycle: each unrecognized episode of hypoglycemia further dulls the body’s ability to detect and respond to the next one. People with HAAF can develop blood glucose levels in the 40s or 50s mg/dL without any of the sweating, shaking, or anxiety that would normally prompt them to eat. The condition is a major cause of severe hypoglycemic events in people with type 1 diabetes and some with long-standing type 2 diabetes. Avoiding hypoglycemia for even a few weeks can partially restore the counterregulatory thresholds, which suggests the blunting is not permanent damage but rather a maladaptive recalibration.
Emergency Treatment and Glucagon as Medicine
When hypoglycemia is severe enough that a person cannot eat or drink, exogenous glucagon becomes the treatment. For decades, the standard rescue kit was an intramuscular injection of reconstituted glucagon powder, which is cumbersome enough that bystanders often struggle with it. Intranasal glucagon, a dry powder sprayed into the nose, was developed as an alternative. In a randomized trial comparing the two, intranasal glucagon successfully raised blood sugar in about 99% of episodes, compared to 100% for the intramuscular injection. Blood glucose reached target levels in an average of 16 minutes with the nasal spray versus 13 minutes for the injection.15PubMed Central. Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study Both routes produced pharmacological glucagon levels within five minutes, though peak concentrations were somewhat lower with nasal delivery. The practical advantage of not needing to mix a powder, draw up a syringe, and inject someone who may be seizing or unconscious is significant, which is why intranasal glucagon has become widely adopted.
Overnight and Between Meals
Blood glucose regulation does not pause while you sleep. Overnight, the liver steadily releases glucose through glycogenolysis and gluconeogenesis to keep blood sugar stable during a period when no food is coming in. This process is shaped by circadian rhythms and the structure of sleep itself. Insulin secretion follows a complex oscillatory pattern, with rapid pulses every 10 to 15 minutes layered on top of slower cycles of roughly 90 to 120 minutes. Counterregulatory hormones like glucagon, cortisol, catecholamines, and growth hormone work to raise blood glucose by stimulating liver glucose production or by reducing glucose uptake in peripheral tissues.16Oxford Academic (Endocrine Reviews). Roles of Circadian Rhythmicity and Sleep in Human Glucose Regulation
Cortisol levels naturally rise in the early morning hours, which is part of why blood glucose tends to increase before you wake up, a phenomenon people with diabetes call the “dawn effect.” Growth hormone, which is secreted in large bursts during deep sleep, temporarily reduces tissue sensitivity to insulin, again helping keep glucose available for the brain during the overnight fast. For people on insulin therapy, these overnight hormonal shifts create a tricky balancing act: too much insulin and blood sugar drops dangerously while asleep; too little and it spikes by morning.
An Evolutionary Perspective on Glucose Defense
The elaborate, redundant nature of the counterregulatory system makes more sense when you consider the evolutionary pressures behind it. The brain’s near-absolute dependence on glucose as fuel means that even brief episodes of severe hypoglycemia can be fatal. Over evolutionary time, organisms that could defend their blood sugar with multiple overlapping mechanisms survived periods of famine and intense physical exertion. Comparative physiology research shows that glucose regulation strategies have been conserved or modified across many species in response to different environmental pressures, and that insulin resistance itself can sometimes function as an adaptive response to stressors like starvation, hibernation, or pregnancy.17PubMed. Is insulin resistance an adaptive response? Clues from nature
Some species have taken glucose defense to extremes. Vampire bats and nectar-feeding bats, for instance, have evolved under positive selection on a gene encoding the GLUT3 transporter, which ferries glucose into brain cells with especially high affinity. Because these bats cannot sustain their metabolic needs from liver glycogen alone and face rapid fasting intolerance, enhanced GLUT3 function appears to protect their brains during metabolic stress.18Nature Ecology & Evolution. Sugar assimilation underlying dietary evolution of Neotropical bats Humans lack that specialization but make up for it with the layered hormonal and neural defense system described throughout this article: glucagon first, then adrenaline, then cortisol and growth hormone, all coordinated by glucose-sensing neurons in the brain. The redundancy is not wasteful engineering; it reflects millions of years of selection pressure against letting blood sugar fall unchecked.
The Gut’s Emerging Role
Most textbook diagrams of the blood glucose counterregulatory response stop at the pancreas, liver, adrenals, and brain. But the gut microbiome is increasingly recognized as a player in glucose metabolism. The trillions of bacteria in the intestine produce short-chain fatty acids, influence bile acid composition, and modulate the release of gut hormones, all of which can affect how the liver handles glucose and how sensitive tissues are to insulin.19PubMed Central. Mechanisms Linking the Gut Microbiome and Glucose Metabolism When the microbial community becomes imbalanced, inflammatory molecules like lipopolysaccharide can leak into the bloodstream and promote insulin resistance, indirectly raising the risk that glucose regulation becomes unstable in both directions. This area of research is still young, and the gut microbiome probably does not participate in the acute minute-to-minute counterregulatory response the way glucagon and adrenaline do. But its influence on the baseline setting of the whole system, how sensitive the body’s glucose thermostat is, how efficiently the liver stores and releases glycogen, may shape how effectively all those faster-acting steps perform when blood sugar starts to fall.